We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
-0.31%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$2.71B
AUM Growth
-$105M
Cap. Flow
-$29.7M
Cap. Flow %
-1.1%
Top 10 Hldgs %
23.72%
Holding
332
New
19
Increased
70
Reduced
176
Closed
23

Sector Composition

Rank Sector Weight
1 Technology 25.75%
2 Healthcare 24.54%
3 Industrials 15.71%
4 Consumer Discretionary 13.79%
5 Communication Services 6.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTZ icon
326
Utz Brands
UTZ
$1.25B
-78,357
Closed -$1.71M
VRNT
327
DELISTED
Verint Systems
VRNT
-49,626
Closed -$2.24M
WW
328
DELISTED
WW International
WW
-125,217
Closed -$4.53M
CSII
329
DELISTED
Cardiovascular Systems, Inc.
CSII
-90,832
Closed -$3.87M
ASPU
330
DELISTED
ASPEN GROUP, INC.
ASPU
-176,125
Closed -$1.15M
INOV
331
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-207,270
Closed -$7.06M
PFPT
332
DELISTED
Proofpoint, Inc.
PFPT
-22,634
Closed -$3.93M

Similar funds

Rice Hall James & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Rice Hall James & Associates held 332 positions worth $2.71B, down 3.7% from $2.81B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Rice Hall James & Associates's Q3 2021 filing shows 19 new, 70 increased, 176 reduced and 23 closed positions. Its largest new stake was GXO Logistics: 305,297 shares worth $23.9M. The largest sale was XPO, an estimated $20.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

  • Rice Hall James & Associates's largest Q3 2021 buy was GXO Logistics: 305,297 shares worth $23.9M.
  • Rice Hall James & Associates added most to Bed Bath & Beyond in Q3 2021, an estimated $7.08M increase.
  • Rice Hall James & Associates's biggest Q3 2021 reduction was XPO, cutting an estimated $20.8M.
  • Rice Hall James & Associates fully exited Nektar Therapeutics in Q3 2021, selling an estimated $8.49M.
  • Rice Hall James & Associates's ten largest holdings make up 24% of its $2.71B portfolio in Q3 2021.
  • Rice Hall James & Associates opened 19 new positions and closed 23 in Q3 2021.
  • Rice Hall James & Associates's portfolio value fell 3.7% quarter-over-quarter to $2.71B.

Based on Rice Hall James & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.